Dr. Christine C. Yokoyama, MD

Dr. Yokoyama practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Yokoyama's NPI, 1588158737, was assigned on June 20, 2018. Dr. Yokoyama graduated from Washington University School of Medicine in 2018. Dr. Yokoyama holds Missouri license 2022019867.

Dr. Yokoyama's primary practice is Washington University School of Medicine, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 747-5192.

Dr. Yokoyama's primary practice is Washington University School of Medicine in Saint Louis, Missouri. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Yokoyama to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yokoyama practices. Vendor and product names are available with a free account.

Dermatology is Dr. Yokoyama's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Yokoyama is licensed in Missouri.

CMS data shows 76 Medicare services from Dr. Yokoyama across 4 procedure codes in 2024, for 66 Medicare patients. Medicare paid $5,309 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Dr. Yokoyama in 2024. The largest group is 65 to 74, with 36 patients. 70% of them have high cholesterol, and 62% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yokoyama's median patient age at 47, with 79% women.

In 2024, Dr. Yokoyama wrote 257 Medicare Part D claims for 54 patients. 82% of them were for generic drugs. CMS names the drug for 180 of them, across 8 drugs with 11 or more claims each, at $118,881 in total drug cost. In 2023, CMS named 106 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Yokoyama for performance year 2024, reported as part of a group. Dr. Yokoyama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of removal of skin lesions by Dr. Yokoyama, more than 70% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Yokoyama, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are HN Protein, Viral Fusion Proteins and Cell Line. Dr. Yokoyama has published most often in JAAD Case Rep. Dr. Yokoyama's most frequent co-authors are Amy C. Musiek, MD, Ilana Shaina Rosman, MD and Milan Jatin Anadkat, MD.

CMS Open Payments shows 4 general payments to Dr. Yokoyama from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $129.

Dr. Yokoyama graduated from Washington University School of Medicine in 2018.